|
|
|
Insider
Information: |
Novak Rodger |
Relationship: |
President, Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
573,007 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$32,214,454 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
573,007 |
|
|
Total
Value |
$32,214,454 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Crispr Therapeutics Ag |
CRSP |
President, Director |
2021-06-30 |
573,007 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CRSP |
Crispr Therapeutics Ag |
Chief Executive OfficerOfficer |
|
2016-10-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,215,005 |
|
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-04-19 |
4 |
OE |
$1.81 |
$86,348 |
D/D |
47,706 |
1,262,711 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-04-19 |
4 |
AS |
$17.57 |
$854,066 |
D/D |
(47,706) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-04-20 |
4 |
OE |
$1.81 |
$4,152 |
D/D |
2,294 |
1,217,299 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-04-20 |
4 |
AS |
$17.37 |
$39,852 |
D/D |
(2,294) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-02 |
4 |
AS |
$16.53 |
$263,236 |
D/D |
(15,924) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-02 |
4 |
OE |
$1.81 |
$28,822 |
D/D |
15,924 |
1,230,929 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-03 |
4 |
OE |
$1.81 |
$36,687 |
D/D |
20,269 |
1,235,274 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-03 |
4 |
AS |
$16.05 |
$325,986 |
D/D |
(20,269) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-04 |
4 |
AS |
$16.37 |
$215,960 |
D/D |
(13,191) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-04 |
4 |
OE |
$1.81 |
$23,876 |
D/D |
13,191 |
1,229,196 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-05 |
4 |
OE |
$1.81 |
$1,115 |
D/D |
616 |
1,215,621 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-05 |
4 |
AS |
$16.92 |
$10,426 |
D/D |
(616) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-16 |
4 |
OE |
$1.81 |
$43,579 |
D/D |
24,077 |
1,239,082 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-16 |
4 |
AS |
$16.50 |
$397,283 |
D/D |
(24,077) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-17 |
4 |
OE |
$1.81 |
$46,921 |
D/D |
25,923 |
1,240,928 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-17 |
4 |
AS |
$16.03 |
$415,577 |
D/D |
(25,923) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-30 |
4 |
AS |
$15.02 |
$54,829 |
D/D |
(3,650) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-05-30 |
4 |
OE |
$1.81 |
$6,607 |
D/D |
3,650 |
1,218,655 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-06-08 |
4 |
OE |
$1.81 |
$7,607 |
D/D |
4,203 |
1,219,208 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-06-08 |
4 |
AS |
$15.00 |
$63,045 |
D/D |
(4,203) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-06-09 |
4 |
OE |
$1.81 |
$1,991 |
D/D |
1,100 |
1,216,105 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-06-09 |
4 |
AS |
$15.08 |
$16,583 |
D/D |
(1,100) |
1,215,005 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-06-19 |
4 |
OE |
$1.81 |
$27,860 |
D/D |
15,392 |
1,230,397 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
|
2017-06-19 |
4 |
AS |
$15.00 |
$230,880 |
D/D |
(15,392) |
1,215,005 |
0 |
- |
|
67 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|